Centricity Research Brampton Endocrinology

Brampton L6S 6J6

1 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Hypertriglyceridemia, Type 2 Diabetes

Studies at this site

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide — Recruiting now
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed